APA

Graff G. R., McNamara J., Royall J., Caras S. & Forssmann K. (20100722). Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study. : Clinical drug investigation.

Chicago

Graff Gavin R, McNamara John, Royall James, Caras Steven and Forssmann Kristin. 20100722. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study. : Clinical drug investigation.

Harvard

Graff G. R., McNamara J., Royall J., Caras S. and Forssmann K. (20100722). Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study. : Clinical drug investigation.

MLA

Graff Gavin R, McNamara John, Royall James, Caras Steven and Forssmann Kristin. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study. : Clinical drug investigation. 20100722.